Spurious hyperphosphatemia in a case of multiple myeloma.
A 50 year old male was admitted in our hospital with anemia and impaired renal function. He was subsequently found to have extremely elevated serum phosphate level (24 mg/dL, reference interval: 2.5-4.5 mg/dL) with normal serum calcium when assayed on a Beckman Coulter AU 480(®) analyser. Clinico-biochemical discrepancy led to the suspicion of spurious hyperphosphatemia. Serum total protein was grossly elevated with gross reversal of albumin to globulin ratio. Serum electrophoresis revealed a large M band and was confirmed as Ig G-Kappa type on immunofixation. Subsequently a bone marrow aspiration biopsy confirmed the diagnosis of multiple myeloma. The patient serum was then reassayed for phosphate on a Vitros(®) 250 Dry Chemistry platform and the result was within normal reference interval. Paraproteinemias are a common cause of analytical interference in clinical biochemistry laboratories and as multilayered film technology platforms like Vitros(®) assay most routine analytes on a protein free filtrate they are unaffected by paraprotein interference. Clinically discordant patient results should always be interpreted keeping such interferences in mind.
Department of Biochemistry, Peerless Hospital & B K Roy Research Centre, Kolkata, 700094 West Bengal India.
Sutirtha
S
Chakraborty
Department of Biochemistry, Calcutta Medical Research Institute, Kolkata, India.
Susruta
S
Sen
Department of Microbiology, Peerless Hospital & B K Roy Research Centre, Kolkata, India.
Debkishore
D
Gupta
Department of Biochemistry, Peerless Hospital & B K Roy Research Centre, Kolkata, 700094 West Bengal India.
Sidhartha Sankar
SS
Ghosh
Mumbai, India.
Prasad
P
Sawant
Department of Biochemistry, Calcutta Medical Research Institute, Kolkata, India.
Mandrita
M
Das
Hyperphosphatemia; Interference; Multiple myeloma; Paraprotein